Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 82 results found. Search for [ NPPA ]

Results 1 to 21 of 82
Joe C Mathew
New Delhi, February 20, 2018
National Pharmaceutical Pricing Authority (NPPA) has found that over 25 percent of the bill charged by four private hospitals in the National Capital Region of Delhi on some of their patients was on drugs that were out of price control.


www.businesstoday.in
February 15, 2018



www.businesstoday.in
February 12, 2018



www.businesstoday.in
December 27, 2017



Joe C Mathew
New Delhi, December 21, 2017
Dharam Vira Gandhi, a parliamentarian from Punjab and a qualified medical practitioner, has sought urgent intervention of the Prime Minister to ensure affordable healthcare to all citizens.


BusinessToday.in
New Delhi, December 18, 2017
Last week, National Pharmaceutical Pricing Authority (NPPA) broughtto the public domain the retail price and trade margin details of all themedicines and consumables that were billed by a leading pan-Indian hospitalchain while treating a dengue patient in a hospital in Gurugram


E Kumar Sharma
December 17, 2017
On Friday, the National Pharmaceutical Pricing Authority without either pronouncing Fortis guilty or absolving it of any wrong doing, just confined itself to saying: \"NPPA shall be taking necessary follow up action as per existing law and within its jurisdiction.\"


E Kumar Sharma
New Delhi, October 24, 2017
On October 20th the ministry of chemicals and fertilizers issued a press note in what seems an attempt to allay industry fears on the issue of price controls.


E Kumar Sharma
New Delhi, September 1, 2017
An integrated and unified approach in the handling affairs concerning health and medicines in the country, could go a long way in unlocking the huge potential of the industry,says DCGI GN Singh.


Joe C Mathew
New Delhi, August 31, 2017
The Medical Technology Association of India (MTaI), a representative body of the domestic arm of global medical device makers, has asked the drug price regulator National Pharmaceutical Pricing Authority (NPPA) to review its decision to cap the prices of knee implants.


Joe C Mathew
New Delhi, August 22, 2017
NGO Medicines Sans Frontiers had challenged the patent claims of Pfizer, calling it way to gain market monopoly. The MSF has argued that Indian firms can supply the same vaccine for much less.


E Kumar Sharma
New Delhi, August 21, 2017
Certain pharma industry leaders point out that the draft of new pharmaceutical policy has been written in an amateurish manner.


Joe C Mathew
New Delhi, August 18, 2017
NPPA Chairman Bhupendra Singh said that a similar exercise to identify the price patterns prevailing in medical device sector is underway.


Joe C Mathew
New Delhi, August 18, 2017
MTaI argued that knee replacement surgery is not a life-threatening procedure but an elective surgery as the patient is free to choose to go for it or go for alternate therapies.


Joe C Mathew
New Delhi, August 17, 2017
NPPA stated that the decision was taken after it was noticed that orthopedic-knee implants were having unjustified, unreasonable and irrational high trade margins leading to their exorbitant prices.


Mail Today Bureau
July 14, 2017
For instance, Emcure Pharmaceuticals was offering its drug Temcure 250 mg to an Amritsar-based cancer hospital at just Rs 1,950 while  patients have to pay about nine times more at  Rs 18,647.


Team BT
New Delhi, June 28, 2017
The world cannot blame you if you have been smitten by the shopping bug ahed of the GST roll out. You must have been getting SMS messages from various brands announcing their special sale offers till June 30. 


Mail Today Bureau
New Delhi, June 28, 2017
Ahead of the GST rollout on July 1, the National Pharmaceutical Pricing Authority (NPPA) on Tuesday announced provisional ceiling prices of 761 medicines which includes a list of antibiotics and drugs for treating cancer, HIV, diabetes.


Reuters
June 19, 2017
In a letter sent to the Indian ambassador to Washington last month, 18 members of Congress said they were \"troubled\" by the price cap, warning that it could deter firms from launching new medical products in India.


PTI
New Delhi, June 13, 2017
The government has fixed GST rate of 12 per cent on most of the essential drugs as against the current tax incidence of around 9 per cent.


PAGES 1 OF 5  12345